{"id":13315,"date":"2017-12-01T15:23:01","date_gmt":"2017-12-01T14:23:01","guid":{"rendered":"http:\/\/k2info.w.uib.no\/?p=13315"},"modified":"2017-12-01T15:18:08","modified_gmt":"2017-12-01T14:18:08","slug":"evalueringenes-tider-er-over-oss","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/nb_no\/2017\/12\/01\/evalueringenes-tider-er-over-oss\/","title":{"rendered":"[:no]Evalueringenes tider er over oss[:en]Time for evaluation is here[:]"},"content":{"rendered":"

[:no]\"\"<\/a>Komiteene for de ulike finansieringskildene (Norges forskningsr\u00e5d, Kreftforeningen, etc.) har brukt h\u00f8sten til \u00e5 endevende s\u00f8knadene og CV-ene for \u00e5 velge ut de opp mot ti prosentene de synes skal finansieres. Resultatene fra Norges forskningsr\u00e5ds program FRIMEDBIO viser at den nye komiteen som ble etablert sommeren 2017, ikke har funnet forskningen ved K2 verdig finansiering. I realiteten ble det lav uttelling i \u00e5r fra NFR.<\/p>\n

S\u00e5 hva med \u00e5 sette seg p\u00e5 andre siden av bordet? N\u00e5 er ikke Forskningsr\u00e5det p\u00e5 tilbudssiden, der m\u00e5 man inviteres inn i komiteen, men EUs Horisont 2020 program oppfordrer forskere til \u00e5 registrere seg i ekspertdatabasen. Det er to ting de ser etter: at en har h\u00f8y ekspertise innen relevante fagfelt, og er tilgjengelig for tilfeldige korttidsoppdrag. Det er flere avgj\u00f8rende faktorer ved utvelgelsen av evaluatorer til en gitt utlysning. I tillegg til \u00e5 se p\u00e5 den faglige ekspertisen, er kj\u00f8nn og geografisk spredning ogs\u00e5 viktige faktorer.<\/p>\n

Det er mange fordeler ved \u00e5 v\u00e6re evaluator. Du f\u00e5r innsikt i prosessen og skaffer deg erfaring med hvordan en evaluering gjennomf\u00f8res. Du f\u00e5r mulighet til \u00e5 lese flere s\u00f8knader, b\u00e5de gode og d\u00e5rlige, og f\u00e5r informasjon om hvilket niv\u00e5 som forventes, og hva en b\u00f8r unng\u00e5. Denne erfaringen er ogs\u00e5 nyttig for s\u00f8knadsskriving ved nasjonale utlysninger, som i stadig st\u00f8rre grad kopierer EU-utlysninger.<\/p>\n

Istedenfor \u00e5 gi en detaljert beskrivelse av registreringsprosessen har jeg satt av 19. desember og 10. januar til \u00e5 bist\u00e5 dere. Kom gjerne innom kontoret mitt eller inviter meg p\u00e5 bes\u00f8k.<\/p>\n

Amra[:en]\"\"<\/a>Committees from various funding sources (Research Council of Norway, Norwegian Cancer Society, etc.) have spent the autumn analyzing applications and CVs to seal out the around ten percent they think should be funded. The results from the Research Council of Norway\u2019s program FRIMEDBIO show that the new committee established during summer 2017 has not found research at K2 worthy of being funded. In reality, success rates were poor from the Research Council of Norway this year.<\/p>\n

So, what about getting on the other side of the fence? For the Research Council of Norway, you need to be invited to sit in the committee, but EU\u2019s Horizon2020 program encourages researchers to register in the expert database. They are looking for two things: high expertise in relevant research field, and that you are available for random short-term assignments. The European Commission considers several factors when choosing evaluators for a call. In addition to scientific qualifications, gender and geographical spread are important factors.<\/p>\n

There are many advantages of being an evaluator. You will get direct insight into the process and gain experience with the evaluation process. You will get the opportunity to read several proposals, both good and bad, and will learn which level is expected and what to avoid. This experience is useful when writing proposals for national announcements, which, to an ever-increasing degree, copy EU announcements.<\/p>\n

Instead of providing you with a detailed description of the registration process, I have reserved 19 December and 10 January to assist you. You are welcome to come by my office, or invite me over.<\/p>\n

Amra[:]<\/p>\n","protected":false},"excerpt":{"rendered":"

[:no]Komiteene for de ulike finansieringskildene (Norges forskningsr\u00e5d, Kreftforeningen, etc.) har brukt h\u00f8sten til \u00e5 endevende s\u00f8knadene og CV-ene for \u00e5 velge ut de opp mot ti prosentene de synes skal finansieres. Resultatene fra Norges forskningsr\u00e5ds program FRIMEDBIO viser at den…<\/p>\n

Read more →<\/a><\/p>\n","protected":false},"author":3699,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44,39969],"tags":[],"class_list":["post-13315","post","type-post","status-publish","format-standard","hentry","category-nyheter","category-ukens-leder"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/13315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/users\/3699"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/comments?post=13315"}],"version-history":[{"count":2,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/13315\/revisions"}],"predecessor-version":[{"id":13317,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/13315\/revisions\/13317"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/media?parent=13315"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/categories?post=13315"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/tags?post=13315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}